Karmanos Cancer Institute (Site 070)

Detroit, Michigan 48201

0 studies enrolling now · 1 studies all time

What they study most

Advanced Malignancies, Carcinoma, Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer — NO_LONGER_AVAILABLE